Status:
COMPLETED
Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone
Lead Sponsor:
HanAll BioPharma Co., Ltd.
Conditions:
Hypertension
Eligibility:
MALE
20-50 years
Phase:
PHASE1
Brief Summary
Clinical trial to evaluate the pharmacokinetic interactions and safety between telmisartan and chlorthalidone.
Eligibility Criteria
Inclusion
- Healthy male subjects
- Age(yr)between 20 and 50
- Signed written informed consent
Exclusion
- Known hypersensitivity to investigator product, thiazide, sulphonamide and other drugs or additive.
- History of any siginificant Sickness, Cardiovascular, Respiratory, Renal, Endocrine, Neurological, Psychic, Cancer, Gasstrointestinal, Hematologic.
- History of drug and/or alcohol abuse
- Over 10 tobaccos a day
- Other condition which in the opinion of the investigator preclude enrollment into the study
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01806363
Start Date
November 1 2012
End Date
June 1 2013
Last Update
February 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyungpook national university hospital Clionical center
Daegu, Gyeongsangbuk-do, South Korea, 700-721